Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of recombinant angiostatin to prevent retinal neovascularization.

× No keyword cloud information.

10 in total

1. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.

Authors: Z Yan; Y Zhang; D Duan; J F Engelhardt
Journal: Proc Natl Acad Sci U S A Date: 2000-06-06 Impact factor: 11.205

2. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.

Authors: W G Kearns; S A Afione; S B Fulmer; M C Pang; D Erikson; M Egan; M J Landrum; T R Flotte; G R Cutting
Journal: Gene Ther Date: 1996-09 Impact factor: 5.250

3. Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth.

Authors: P I Meneses; L E Abrey; K A Hajjar; S H Gultekin; R M Duvoisin; K I Berns; M R Rosenfeld
Journal: Clin Cancer Res Date: 1999-11 Impact factor: 12.531

4. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Authors: M Cavazzana-Calvo; S Hacein-Bey; G de Saint Basile; F Gross; E Yvon; P Nusbaum; F Selz; C Hue; S Certain; J L Casanova; P Bousso; F L Deist; A Fischer
Journal: Science Date: 2000-04-28 Impact factor: 47.728

5. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.

Authors: J A Wagner; A H Messner; M L Moran; R Daifuku; K Kouyama; J K Desch; S Manley; A M Norbash; C K Conrad; S Friborg; T Reynolds; W B Guggino; R B Moss; B J Carter; J J Wine; T R Flotte; P Gardner
Journal: Laryngoscope Date: 1999-02 Impact factor: 3.325

Use of recombinant angiostatin to prevent retinal neovascularization.

1. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.

2. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.

3. Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth.

4. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

5. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.

6. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.

7. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors.

8. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle.

9. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter.

10. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.